Xeris Biopharma rises on report of Lundbeck takeover interest
BUZZ-Xeris Biopharma rises on report of Lundbeck takeover interest ** Shares of Xeris Biopharma XERS.O rise 2.8% to $10.08
** Lundbeck A/S HLUNa.CO has expressed interest in acquiring Xeris Biopharma Holdings, Bloomberg News reports, citing people familiar with the matter
** Lundbeck and Xeris Biopharma did not immediately respond to Reuters requests for comment
** The Danish pharmaceuticals company has been working with advisers to explore a takeover of Chicago-based Xeris, the report says
** Up to last close, XERS up 27.9% YTD
(Reporting by Siddhi Mahatole)
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Files Patent Infringement Lawsuits In US District Court - SEC Filing
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
Lundbeck expresses interest in buying Xeris, Bloomberg News reports (updated)
Xeris Biopharma rises on report of Lundbeck takeover interest